血清可溶性PD-L1水平纵向变化及中性粒细胞PD-L1 mRNA表达与综合ICU异质性人群结局的关联
本研究为前瞻性研究,纳入42例综合ICU危重患者,在入ICU 24-48小时内及第4、8、13天检测血清sPD-L1和中性粒细胞PD-L1 mRNA表达,并检测基线IL-6、IL-8、IL-10、TNF-α。结果显示,入ICU时血清sPD-L1与CRP及IL-6、IL-8、IL-10正相关,基线中性粒细胞PD-L1 mRNA与γ-球蛋白及TNF-α正相关。血清sPD-L1水平的纵向变化是ICU死亡的独立危险因素(OR 2.58,95%CI 1.17-5.72,P=0.02)。作者认为其可能作为预后标志物,并可能指导严重免疫抑制危重患者的免疫调节治疗。
要点
- 在42例综合ICU患者中,血清sPD-L1水平的纵向变化是ICU死亡的独立危险因素(OR 2.58,95%CI 1.17-5.72,P=0.02)。
- 入ICU时血清sPD-L1与CRP及IL-6、IL-8、IL-10正相关。
- 基线中性粒细胞PD-L1 mRNA表达与γ-球蛋白及TNF-α正相关。
- 研究纳入42例患者,男性25例(60%),中位年龄57(41-71)岁,中位APACHE II评分16(12-20),SOFA评分8(7-10)。
- 创伤为21例(50%)患者的入ICU诊断,全因ICU死亡率为35%。
适用人群与场景
- 纳入综合ICU收治的危重患者,最终分析42例;男性25例(60%),中位年龄57(41-71)岁,中位APACHE II评分16(12-20),SOFA评分8(7-10),创伤为21例(50%)患者的入ICU诊断。
研究设计与关键结果
- 研究类型为前瞻性研究,样本量42例,人群为综合ICU危重患者;在入ICU 24-48小时内(基线)及第4、8、13天检测血清sPD-L1和中性粒细胞PD-L1 mRNA相对表达,并检测基线IL-6、IL-8、IL-10、TNF-α。
- 入ICU时血清sPD-L1与CRP及IL-6、IL-8、IL-10正相关;基线中性粒细胞PD-L1 mRNA表达与γ-球蛋白及TNF-α正相关。
- 血清sPD-L1水平的纵向变化是ICU死亡的独立危险因素(OR 2.58,95%CI 1.17-5.72,P=0.02)。
- 全因ICU死亡率为35%。
证据类型、等级与局限
- 证据类型为前瞻性研究;原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为血清sPD-L1水平的动态变化可能作为预后标志物,并可能指导严重免疫抑制危重患者的免疫调节治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Introduction: Immunosuppression is a common phenomenon in critically ill patients, regardless of sepsis presence. The interaction between programmed cell death-1 (PD-1) and programmed cell death-ligand 1 (PD-L1) is believed to play a significant role in immunosuppression. The primary aim of this study was to investigate the association between the dynamic changes of two negative co-stimulatory markers, neutrophil PD-L1 mRNA expression and serum soluble PD-L1 (sPD-L1) levels, and clinical outcome in a heterogeneous population of patients admitted to a general intensive care unit (ICU). Methods : This prospective study included critically ill patients admitted to a multidisciplinary ICU. Baseline levels of interleukin (IL)-6, IL-8, IL-10, and tumor necrosis factor (TNF)-α were measured. Serum sPD-L1 and neutrophil PD-L1 mRNA relative expression were measured within 24-48 h of admission (baseline) and on days 4, 8, and 13, using ELISA. Data were analyzed using mixed-effects linear and logistic regression models. Results : A total of 42 patients were included in the final analysis, with 25 (60%) being male. The median age (IQR) was 57 (41-71) years, and the median APACHE II and SOFA scores were 16 (12-20) and 8 (7-10), respectively. Trauma was the admission diagnosis for 21 (50%) patients, and the all-cause ICU mortality rate was 35%. Admission serum sPD-L1 was positively correlated with C-reactive protein and IL-6, 8 and 10. Baseline neutrophil PD-L1 mRNA expression was positively correlated with γ-globulins and TNF-α. The longitudinal change in serum sPD-L1 levels was identified as an independent risk factor for ICU mortality (OR: 2.58, 95% CI: 1.17-5.72, P = 0.02). Conclusion : The dynamic change in serum sPD-L1 levels over time was independently associated with ICU outcome, highlighting their potential role as a prognostic marker. It could also guide immunomodulatory treatment in critically ill patients with severe immunosuppression.
参考来源
- Kokkoris S, Keskinidou C, Jahaj E, et al. ASSOCIATION BETWEEN LONGITUDINAL CHANGES IN SERUM SOLUBLE PD-L1 LEVELS AND NEUTROPHIL PD-L1 MRNA EXPRESSION WITH OUTCOME IN A HETEROGENEOUS GENERAL ICU POPULATION. Shock. 2025. PMID: 40208036. doi:10.1097/SHK.0000000000002602
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。